Firas El Chaer

12PUBLICATIONS
23CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsHaematological tumoursMedical bacteriologyGene and molecular therapyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 25, 2025
Measurable residual mutated NPM1 before allogeneic transplant for acute myeloid leukemia.

Rasha W Al-Ali, Gege Gui, Niveditha Ravindra

|Nov 27, 2024
Evaluation of Gemtuzumab Ozogamicin and Anthracycline Dosing for Favorable Risk Acute Myeloid Leukemia.

Joseph F Mort, David Brighton, Samantha DiBenedetto

|Nov 04, 2024
Pre-emptive therapeutic decisions based on measurable residual disease status in acute myeloid leukemia: ready for prime time?

Firas El Chaer, Anthony J Perissinotti, Sanam Loghavi

|Feb 09, 2023
How I treat AML incorporating the updated classifications and guidelines.

Firas El Chaer, Christopher S Hourigan, Amer M Zeidan

|Jul 01, 2022
How I treat and prevent COVID-19 in patients with hematologic malignancies and recipients of cellular therapies.

Firas El Chaer, Jeffery J Auletta, Roy F Chemaly

|May 26, 2022
MRD in ALL: Optimization and Innovations.

Eric Pierce, Benjamin Mautner, Joseph Mort

Pageof 2

Frequent Collaborators

2 joint publications

Jeffery J Auletta

2 joint publications

Christopher S Hourigan

1 joint publications

Ali Bukhari

1 joint publications

Michael T McCurdy